BIOA
BioAge Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.06
−0.37%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.66
- Revenue estimate
- $1.5M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.58
- EPS estimate
- -$0.61
- Revenue actual
- $2.5M
- Revenue estimate
- $1.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +13.2%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $33
- PT range
- $25 – $40
- Analysts
- 3
3 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.61 | -$0.58 | Beat 4.50% | $2.5M |
| May 8, 2026 | -$0.64 | -$0.52 | Beat 18.70% | $2.8M |
| Mar 24, 2026 | -$0.83 | -$0.72 | Beat 13.25% | $3.1M |
| Nov 6, 2025 | -$0.67 | -$0.56 | Beat 16.42% | $2.1M |
| Mar 20, 2025 | -$0.58 | -$1.97 | Miss -239.66% | — |
| Nov 7, 2024 | -$0.72 | -$6.70 | Miss -830.56% | — |
| Sep 26, 2024 | — | -$1.80 | — | — |
| Mar 31, 2024 | — | -$1.74 | — | — |
| Dec 31, 2023 | — | -$2.81 | — | — |
| Sep 30, 2023 | — | -$1.96 | — | — |
| Jun 30, 2023 | — | -$2.30 | — | — |
| Mar 31, 2023 | — | -$1.48 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026